An adjunctive panel can be suggested, including CD10, EMA, cathepsin K, c-kit, HNF1β, and E-cadherin, following a primary screening panel of the CK7-CAIX-AMACR algorithm, which is the most efficient strategy for subtyping of RCC. Here, CDH1 is linked to renal cell carcinoma.